Literature DB >> 11374855

Nonpharmacologic management of low levels of high-density lipoprotein cholesterol.

H N Ginsberg1.   

Abstract

Several nonpharmacologic approaches can effectively increase low serum levels of high-density lipoprotein cholesterol (HDL-C), including weight control, specific nutritional choices, exercise, alcohol consumption, and smoking cessation. Increased visceral fat is inversely associated with HDL-C in both men and women. During weight reduction, HDL-C, HDL2-C, and apolipoprotein A-1 (apo A-1) tend to decrease, but levels increase with sustained weight loss. Overall, weight cycling is not detrimental in terms of serum lipids. Increasing monounsaturated fat intake and reducing carbohydrates increases HDL-C levels. Lowering trans-fatty acid intake also improves serum lipids. A very low-fat diet combined with stress-lowering lifestyle changes has been shown to cause regression of coronary artery disease. Moderate alcohol consumption, even in diabetic patients, and smoking cessation can increase serum HDL-C levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11374855     DOI: 10.1016/s0002-9149(00)01469-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  High-density lipoprotein subfractions and risk of coronary artery disease.

Authors:  John Morgan; Christina Carey; Anne Lincoff; David Capuzzi
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

Review 2.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

Review 3.  Effects of diet on high-density lipoprotein cholesterol.

Authors:  Patty W Siri-Tarino
Journal:  Curr Atheroscler Rep       Date:  2011-12       Impact factor: 5.113

4.  Vital exhaustion in relation to lifestyle and lipid profile in healthy women.

Authors:  Jenny C Koertge; Staffan Ahnve; Karin Schenck-Gustafsson; Kristina Orth-Gomer; Sarah P Wamala
Journal:  Int J Behav Med       Date:  2003

5.  HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular disease.

Authors:  Gerald F Watts; John R Burnett
Journal:  Clin Biochem Rev       Date:  2004-02

6.  Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities.

Authors:  Gerald F Watts
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

7.  Metabolic Syndrome Associated with Tobacco and Caffeine Products Use Among Refugee Adolescents: Risk of Dyslipidemia.

Authors:  Basma Damiri; Omar Khatib; Zaher Nazzal; Diala Sanduka; Siwar Igbaria; Ammar Thabaleh; Ahmad Farhoud; Lubna Saudi; Souad Belkebir; Rayyan Al Ali; Mohammed Alili; Mahmoud Hamdan; Omar A Safarini; Omar Younis
Journal:  Diabetes Metab Syndr Obes       Date:  2021-09-29       Impact factor: 3.168

8.  Changes in triglyceride levels over time and risk of type 2 diabetes in young men.

Authors:  Amir Tirosh; Iris Shai; Rafael Bitzur; Ilan Kochba; Dorit Tekes-Manova; Eran Israeli; Tzippora Shochat; Assaf Rudich
Journal:  Diabetes Care       Date:  2008-06-30       Impact factor: 17.152

Review 9.  The Effects of Bikram Yoga on Health: Critical Review and Clinical Trial Recommendations.

Authors:  Zoe L Hewett; Birinder S Cheema; Kate L Pumpa; Caroline A Smith
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-05       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.